| Patent application number | Description | Published |
|---|
| 20080318968 | Chemical Compounds - The invention relates to a novel group of compounds of Formula (I) or a salt thereof: | 12-25-2008 |
| 20090018134 | Compounds - 945 - A compound of formula (I) | 01-15-2009 |
| 20090111790 | HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES - Compounds of formula (I) | 04-30-2009 |
| 20100173825 | HETEROARYL BENZAMIDE DERIVATIVES - The invention relates to a novel group of compounds of Formula (I) or a salt thereof: | 07-08-2010 |
| 20100227858 | TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES - A compound of formula (I) or a pharamaceutically acceptable salt thereof, processes for their preparation, pharmaceutical compositions containing them and their use intherapy, for example in the treatment of proliferative disease such as cancer and particularly in disease mediated by an mTOR kinase and/or one or more PI3K enzyme. | 09-09-2010 |
| 20100249131 | MORPHOLINO PYRIMIDINE DERIVATIVES USED IN DISEASES LINKED TO MTOR KINASE AND/OR PI3K - A compound of formula (I) or a pharamaceutically acceptable salt thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example in the treatment of proliferative disease such as cancer and particularly in disease mediated by an mTOR kinase and/or one or more PI3K enzyme. | 09-30-2010 |
| 20110034432 | BENZAMIDE DERIVATIVES AND THEIR USE AS GLUCOKINASE ACTIVATING AGENTS - Compounds of Formula (I): | 02-10-2011 |
| 20110034454 | MORPHOLINO PYRIMIDINE DERIVATIVES AND THEIR USE IN THERAPY - A compound of formula (I) or a salt, ester or prodrug thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example in the treatment of proliferative disease such as cancer and particularly in disease mediated by an mTOR kinase and/or one or more PI3K enzyme. | 02-10-2011 |
